bookmark abstract background finding conclusion finding abbreviation competing interest author contribution detail reference aalberse clinical translational allergy brief communication open access plasma elevated subgroup patient clinical reactivity peanut joost aalberse anders van thuijl yolanda meijer wilco jager tjitske van der palen merkus aline sprikkelman maarten hoekstra berent prakken femke van wijk abstract background one family member implicated initiation amplification response animal model associated airway hyper reactivity involvement also food allergic disease remains investigated finding study thirty child suspected peanut allergic disease underwent double blind placebo controlled food challenge dbpcfc plasma level determined challenge highly elevated subgroup child positive dbpcfc outcome plasma absent child negative dbpcfc outcome healthy control conclusion study show family member highly elevated child clinical response peanut suggests role pathogenesis peanut allergy elevated plasma may sign severe atopic phenotype keywords dbpcfc family peanut allergy finding member cytokine family emerging key factor immune response prototypic family member trigger pro inflammatory mune response contributes neutrophilia chronic airway inflammation also known divergent cytokine family unlike member identified central player initiation amplification response experimental mouse model diates early differentiation towards phenotype development airway hyper reactivity allergic disease moreover allergen provocation asth matic patient increase expression receptor suggesting implicated sensitization memory response airway hypersen sitivity increased duodenal level found peanut allergy mouse study human subject however involvement food correspondence mailto vanwijk umcutrecht vanwijk umcutrecht laboratory translational immunology department paediatric immunology university medical centre box utrecht netherlands full list information available end article peanut allergy remains unknown investigate difference expression peanut allergic versus peanut tolerant peanut sensi tized clinical reactive determined plasma level well cytokine well defined cohort peanut sensi tized child undergoing double blind placebo con trolled food challenge dbpcfc thirty child suspected peanut allergic disease based either elevated specific ige peanut immu nocap positive skin test peanut referred wilhelmina childrens hospital university medical center utrecht netherlands dbpcfc obtain certainty diagnosis peanut allergy patient characteristic see table study approved local medical ethic view board metc umc utrecht project metc amc amsterdam project informed consent obtained subject oral challenge performed previously described peripheral blood sample collected start dbpcfc well challenge fin ished plasma cytokine level determined xmap technology luminex austin aalberse licensee central ltd open access article distributed term creative common attribution license permit unrestricted use distribution reproduction medium provided original work properly cited aalberse clinical translational allergy table characteristic peanut sensitized patient underwent dbpcfc sex age peanut spt asthma atopic clinical response resp syst year specific ige diagnosis diagnosis dermatitis dbpcfc patient non responder peanut challenge patient positive responder peanut challenge asthma diagnosed according at criterion atopic dermatitis diagnosed according criterion hanifin rajka spt skin prick test number represents wheal size ratio peanut compared histamine dbpcfc double blind placebo controlled food challenge performed child elevated plasma determined figure gastrointestinal symptom including stomach ache nausea vomiting diarrhea resp respiratory symptom including rhinorrhea stuffy nose syst systemic symptom including shortage breath systemic urticaria angioedema dbpcfc resulted positive allergic negative tolerant challenge group peanut allergy con firmed patient plasma sample negative positive challenge group found striking difference type related cytokine plasma detected child negative challenge response whereas plasma elevated six child positive challenge group figure five six child concentration even extremely elevated level ranging figure level similar plasma sam ples taken challenge data shown found positive negative challenge group versus child respectively con trast level significantly lower positive challenge negative challenge group figure show cohort peanut sensitized child presence high level plasma present child posi tive challenge clinical reactivity inversely corre lated plasma finding seem aalberse clinical translational allergy figure cytokine profile antibody level peanut sensitised patient colour profile scatter plot plasma level child negative child positive peanut challenge mannwhitney test peanut specific ige total ige serum level negative positive challenge group mannwhitney test positive challenge group subdivided positive negative child rather specific cohort peanut allergic chil dren since plasma level detection limit age matched healthy con trols data shown searched explain plasma ele vated subgroup peanut allergic patient difference found relation cytokine level detection limit level low positive within clinical responder group also difference peanut specific ige level found negative positive sub group figure plasma associate total ige level figure previous exposure peanut severity food allergic symptom presence asthma atopic dermatitis correlate organ specific symptom challenge table often mentioned related asthma like symptom reviewed ige data inhalant allergen plasma level ige either birch house dust mite hdm cat patient available general child peanut sensitization also sensitized inhalation allergen irrespective positive negative chal lenge level extend finding peanut allergic child next measured group infant diagnosed cow milk allergy cma confirmed dbpcfc infant found allergic patient low level level detection level data shown data indicate elevated serum general phenomenon clinical food allergy aalberse clinical translational allergy peanut allergy considered indication broad possibly severe atopic phenotype unlike food allergy cma infrequently outgrown original diagnosis peanut allergy tested cohort based oral challenge pose limitation conclusion resolution pea nut allergy however data demonstrate plasma present child ongoing peanut allergy importantly despite peanut free diet least month together data may indi cate elevated plasma sign chronic mune activation induced provoking allergen represents risk factor devel opment persistence clinical reactivity peanut recently suggested secretion induced disruption epithelial barrier data sufficient make conclusion nature subgroup speculated patient severe type food allergy finding peanut allergic patient displayed highly elevated level stress possibility clinical subgroup within group peanut allergic child warrant larger cohort study expressed variety innate immune cell non hematopoietic cell including basophil eosino phils epithelial endothelial cell gut predominantly found epithelial cell innate lymphoid cell described human respond provide innate source cytokine together increased production triggered environmental antigen microbe gut might therefore contribute atopic phenotype promoting differentiation maintenance allergen specific memory cell conclusion study first show highly elevated subgroup peanut allergic chil dren suggests role development persistence peanut allergy subgroup finding warrant study larger cohort patient well food allergy abbreviation dbpcfc double blind placebo controlled food challenge cma cow milk allergy competing interest author declare competing interest medical centre box utrecht netherlands department paediatric respiratory medicine allergy emma childrens hospital academic medical center amsterdam netherlands department paediatrics university medical centre groningen groningen netherlands sanquin research amsterdam netherlands received june accepted november published december reference iwakura ishigame saijo nakae functional specialization interleukin family member immunity tamachi maezawa ikeda kagami hatano seto suto suzuki watanabe saito tokuhisa iwamoto nakajima enhances allergic airway inflammation amplifying cell dependent path way mouse allergy clin immunol angkasekwinai park wang chang corry liu zhu dong interleukin promotes initiation proallergic type response exp med corrigan wang meng fang eid caballero wang liu kay lee ying allergen induced expression receptor atopic asthmatic airway late phase cutaneous response allergy clin immunol chu llop guevara walker flader goncharova boudreau moore seunghyun waserman coyle kolbeck humbles jordana thymic stromal lymphopoietin cen tral mite peanut allergic sensitization allergy clin immunol aalberse meijer derksen van der palen merkus knol aalberse moving peanut extract peanut component towards validation component resolved ige test allergy jager prakken bijlsma kui rijkers improved multiplex immunoassay performance human plasma synovial fluid following removal interfering heterophilic antibody immunol method skolnick conover walker koerner sampson burk wood natural history peanut allergy allergy clin immunol wang angkasekwinai voo arima hanabuchi hippe corrigan dong homey yao ying huston liu augments type immune response enhancing expansion function tslp activated memory cell exp med zhao urban sun stiltz morimoto notari madden yang grinchuk ramalingam wynn shea donohue critical role nematode infection induced alteration intestinal function immunol mjosberg trifari crellin peter van drunen piet fokkens cupedo spit human responsive type innate lymphoid cell defined expression crth nat immunol licona limon kyun kim palm flavell allergy group innate lymphoid cell nat immunol cite article aalberse plasma elevated subgroup patient clinical reactivity peanut clinical translational allergy author contribution fvw designed research performed patient selection dbpcfc performed experiment fvw analyzed interpreted data fvw wrote paper author read approved final manuscript detail department general paediatrics university medical centre utrecht wilhelmina childrens hospital utrecht netherlands laboratory translational immunology department paediatric immunology university